EDGAR Filing Documents for 0001213900-21-023865

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001213900-21-023865

Filing Date

2021-04-30

Accepted

2021-04-30 16:06:08

Documents

102

Period of Report

2020-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	ANNUAL REPORT	f20f2020_enlivexthera.htm iXBRL	20-F	2234559
2	AMENDMENT, DATED AS OF EFFECTIVE AS OF JANUARY 1, 2020, TO THE CONSULTING AGREEM	f20f2020ex4-24_enlivexthera.htm	EX-4.24	10795
3	LIST OF SUBSIDIARIES OF ENLIVEX THERAPEUTICS LTD	f20f2020ex8-1_enlivexthera.htm	EX-8.1	3300
4	CERTIFICATION	f20f2020ex12-1_enlivexthera.htm	EX-12.1	7203
5	CERTIFICATION	f20f2020ex12-2_enlivexthera.htm	EX-12.2	7218
6	CERTIFICATION	f20f2020ex13-1_enlivexthera.htm	EX-13.1	3538
7	CERTIFICATION	f20f2020ex13-2_enlivexthera.htm	EX-13.2	3510
8	CONSENT OF CONSENT OF YAREL + PARTNERS	f20f2020ex15-1_enlivexthera.htm	EX-15.1	3026
9	GRAPHIC	img_001.jpg	GRAPHIC	12785
10	GRAPHIC	img_002.jpg	GRAPHIC	12909
11	GRAPHIC	img_003.jpg	GRAPHIC	10238
12	GRAPHIC	img_004.jpg	GRAPHIC	32323
13	GRAPHIC	img_005.jpg	GRAPHIC	10992
14	GRAPHIC	img_006.jpg	GRAPHIC	14128
	Complete submission text file	0001213900-21-023865.txt		8028866

Data Files

Seq	Description	Document	Type	Size
15	XBRL SCHEMA FILE	enlv-20201231.xsd	EX-101.SCH	87835
16	XBRL CALCULATION FILE	enlv-20201231_cal.xml	EX-101.CAL	35586
17	XBRL DEFINITION FILE	enlv-20201231_def.xml	EX-101.DEF	303614
18	XBRL LABEL FILE	enlv-20201231_lab.xml	EX-101.LAB	610985
19	XBRL PRESENTATION FILE	enlv-20201231_pre.xml	EX-101.PRE	320827
20	EXTRACTED XBRL INSTANCE DOCUMENT	f20f2020_enlivexthera_htm.xml	XML	948107

Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042

Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616

Enlivex Therapeutics Ltd. (Filer) CIK: 0001596812 (see all company filings)